Literature DB >> 24840077

Melanoma: you can have your cake and eat it!

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24840077     DOI： 10.1038/nrclinonc.2014.85

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.

Authors:  J-J Grob; M M Amonkar; S Martin-Algarra; L V Demidov; V Goodman; K Grotzinger; P Haney; E Kämpgen; B Karaszewska; C Mauch; W H Miller; M Millward; B Mirakhur; P Rutkowski; V Chiarion-Sileni; S Swann; A Hauschild
Journal:  Ann Oncol       Date:  2014-04-25       Impact factor: 32.976
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.